DND Technologies, Inc. (DNDT) Stock Price & Analysis
DND Technologies, Inc. (DNDT) — price $0.165 (-1.43%), as of the Oct 5, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
DND Technologies, Inc. · DNDT
DND Technologies, Inc. operates as a holding company, producing and distributing specialty balms and pharmaceutical products. The company's products include Bioassaygen Gel, Cosmetic Mask, Bio-Skin, and Delivery Gel, sold through wholesale, retail, and internet channels.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.165 | |
| Change on the day | -1.43% | |
| 52-week range | $0.0571 – $1.75 | |
| Shares traded on the day | 8.0K |
Price & events
Other perspectives
Council score for DND Technologies (DNDT): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
9-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 6, 2026, except a card that shows its own read date.
Watch the DNDT film — every key number, told as a short cinematic story
~2 min · open the film
What is DND Technologies (DNDT), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. DND Technologies, Inc. (DNDT) is the company analyzed here. It employs 107 people and is led by David Hong. In Q2 FY2026 it reported revenue of $0 and net income of -$19,040.
What do the latest results show for DND Technologies (DNDT)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $0.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $0 | -$19,040 | -$0.0006 (diluted) |
| Q1 FY2026 | $0 | -$10,500 | -$0.0003 (diluted) |
| Q4 FY2025 | $0 | -$10,500 | -$0.0003 (diluted) |
| Q3 FY2025 | $0 | -$10,500 | -$0.0003 (diluted) |
What are the financial strengths and risks for DND Technologies (DNDT)?
Short answer
The distress and quality screens read Piotroski F 2. Trailing ratios: ROE 2.4% · current ratio 0.00 · earnings yield -0.9%.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 1
- Identified insiders
- 1
- Purchases
- 0
- Sales
- 0
- Other transactions
- 1
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Investor Questions: DNDT Stock
These answers are editorial: 1 of these 8 answers is drawn from the DNDT research dossier (written Mar 18, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is DNDT a good stock to buy?
Stock Expert AI does not rate DNDT buy, sell or hold. DND Technologies, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the DNDT stock price today?
The last price recorded on this page for DND Technologies, Inc. (DNDT) is $0.165, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does DND Technologies, Inc. do?
DND Technologies, Inc. operates as a holding company that produces and distributes specialty balms and pharmaceutical products, primarily under the Bioassaygen brand. Their product line includes gels, masks, and skin replacement bandages designed for skincare and skin regeneration.
What are the key factors to evaluate for DNDT?
Evaluate DNDT on fundamentals, analyst consensus, and risk factors. Investing in research and development to create innovative products could attract new customers and increase brand loyalty. Not financial advice.
How frequently does DNDT data refresh on this page?
DNDT's price is the last quote we recorded, from the Oct 5, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven DNDT's recent stock price performance?
DND Technologies, Inc. (DNDT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary Bioassaygen product line. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DNDT overvalued or undervalued right now?
DND Technologies, Inc. (DNDT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research DNDT before investing?
Before investing in DND Technologies, Inc. (DNDT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (13 figures)
The 13 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 8 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $0.165 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T15:24:48.365Z. | |
px.change | Change on the day | -1.43% | FMP | Financial Modeling Prep (FMP) · quote | |
px.change_abs | Change on the day, in dollars | −$0.0024 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 8.0K | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $0 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q2 FY2026 | -$19,040 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.insiders | Insider transactions via FMP | 1 transactions · 0 purchases, 0 sales, 1 other transactions · 1 identified insiders · most recent available transactions | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. |
UNRECORDED — 5 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $0.0571 – $1.75 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.employees | Employees | 107 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.ceo | Chief executive | David Hong | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Piotroski F 2 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-03 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 2.4% · current ratio 0.00 · earnings yield -0.9% | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.